marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Amneal Pharmaceuticals Income Statement 2011-2024 | AMRX
Annual Income Statement Amneal Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.04 B | 290 M | 660 M | 709 M | 613 M | 1.52 B | - | - | - | - | - | - | - |
Shares |
176 M | 151 M | 149 M | 147 M | 132 M | 127 M | - | - | - | - | - | - | - |
Historical Prices |
5.91 | 1.92 | 4.43 | 4.81 | 4.49 | 12.3 | - | - | - | - | - | - | - |
Net Income |
-79.3 M | -271 M | 13.2 M | 67.8 M | -362 M | -170 M | 168 M | 207 M | - | - | - | - | - |
Revenue |
2.39 B | 2.21 B | 2.09 B | 1.99 B | 1.63 B | 1.66 B | 1.03 B | 1.02 B | - | - | - | - | - |
Cost of Revenue |
1.57 B | 1.43 B | 1.32 B | 1.33 B | 1.15 B | 939 M | 507 M | 421 M | - | - | - | - | - |
Gross Profit |
821 M | 785 M | 769 M | 628 M | 353 M | 716 M | 526 M | 597 M | - | - | - | - | - |
Operating Income |
204 M | -94.9 M | 153 M | 91.2 M | -249 M | -19.7 M | 245 M | 285 M | - | - | - | - | - |
Interest Expense |
5.12 M | 17.8 M | 15.3 M | 2.59 M | 1.46 M | 1.18 M | -47 K | -669 K | - | - | - | - | - |
EBITDA |
271 M | -26.8 M | 213 M | 152 M | 21.7 M | 374 M | 271 M | 307 M | - | - | - | - | - |
Operating Expenses |
- | - | - | - | 539 M | 480 M | 301 M | 324 M | - | - | - | - | - |
General and Administrative Expenses |
430 M | 400 M | 366 M | 327 M | 290 M | 230 M | 109 M | 119 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Amneal Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
310 M | 309 M | 307 M | 154 M | 154 M | 152 M | - | 151 M | 151 M | 150 M | - | 149 M | 149 M | 148 M | - | 148 M | 147 M | 147 M | - | 131 M | 128 M | 128 M | - | 127 M | 127 M | 1 K | 1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-156 K | 5.99 M | -91.6 M | 9.68 M | 11.9 M | -6.94 M | - | -7.61 M | -242 M | -8.82 M | - | -7.78 M | 30 M | 12.7 M | - | -21.6 M | -24.2 M | 120 M | -64.9 M | -265 M | -16.9 M | -47.9 M | -20.3 M | 6.89 M | -17.9 M | - | - | - | - | 42.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
702 M | 702 M | 659 M | 620 M | 599 M | 558 M | - | 546 M | 559 M | 498 M | - | 529 M | 535 M | 493 M | - | 519 M | 465 M | 499 M | 397 M | 378 M | 405 M | 446 M | 498 M | 476 M | 414 M | - | - | 255 M | 260 M | 226 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
433 M | 452 M | 421 M | 388 M | 379 M | 379 M | - | 351 M | 359 M | 323 M | - | 329 M | 323 M | 302 M | - | 353 M | 320 M | 314 M | - | 268 M | 296 M | 310 M | - | 269 M | 235 M | 131 M | - | 120 M | 136 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
270 M | 250 M | 238 M | 233 M | 220 M | 178 M | - | 194 M | 201 M | 175 M | - | 199 M | 212 M | 192 M | - | 134 M | 144 M | 183 M | 110 M | 54.4 M | 105 M | 83.1 M | 193 M | 200 M | 178 M | 145 M | 151 M | 135 M | 124 M | 116 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
88.8 M | 95.5 M | -10.7 M | 75.6 M | 80.1 M | 34.4 M | - | 44.4 M | -199 M | 23.3 M | - | 28.5 M | 67.1 M | 45.9 M | - | 2.44 M | 10.8 M | 57.8 M | - | -112 M | -18.9 M | -94.4 M | - | 74.6 M | -181 M | 63.6 M | - | 78.8 M | 44.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
1.18 M | 4.36 M | 4.07 M | 1.83 M | 417 K | 4.36 M | - | 5.71 M | 6.94 M | 2.12 M | - | 3.87 M | 4.03 M | 794 K | - | 898 K | 571 K | 633 K | - | 446 K | 149 K | 1.11 M | - | -1.01 M | 791 K | 948 K | - | -93 K | -78 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
132 M | 136 M | 29.2 M | 116 M | 121 M | 75.5 M | - | 88.9 M | -157 M | 64.2 M | - | 72.3 M | 111 M | 87.6 M | - | 47 M | 54.7 M | 100 M | - | -74.3 M | 15.9 M | -63.4 M | - | 91.9 M | -166 M | 65.3 M | - | 89.4 M | 54.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
119 M | 116 M | 113 M | 113 M | 106 M | 102 M | - | 100 M | 98.8 M | 98.7 M | - | 91.4 M | 86.2 M | 90.7 M | - | 83.1 M | 80.9 M | 78 M | - | 63.8 M | 67.3 M | 84.4 M | - | 75.5 M | 56 M | 25.1 M | - | 27.4 M | 26.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency